Aethlon Medical (AEMD)

P/S ratio as of April 2026 (TTM): N/A

According to Aethlon Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.5789. At the end of 2025 the company had a P/S ratio of N/A.

P/S ratio history for Aethlon Medical from 2009 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	N/A
2024	N/A	-100%
2023	9.51	-98.03%
2022	482	430.41%
2021	90.8	152.99%
2020	35.9	308.33%
2019	8.79	-93.6%
2018	137	-39.74%
2017	228	319.36%
2016	54.4	-7.5%
2015	58.8	-14.8%
2014	69.0	156.33%
2013	26.9	195.26%
2012	9.12	50.5%
2011	6.06
2010	N/A
2009	N/A

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
PerkinElmer PKI	4.31	N/A	🇺🇸 USA
Pacific Biosciences PACB	2.62	N/A	🇺🇸 USA
Coherent Corp. COHR	7.69	N/A	🇺🇸 USA
Bruker BRKR	1.63	N/A	🇺🇸 USA
Accelerate Diagnostics AXDX	0.0735	N/A	🇺🇸 USA
Inovio Pharmaceuticals INO	428	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Aethlon Medical (AEMD)

P/S ratio as of April 2026 (TTM): N/A